Delivery Order SPE2DX22D0089-SPE2D825F2B50
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $94,955.58 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,847.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,983.12 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contractor,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,745.16 to AmerisourceBergen Drug Corp on June 23, 2025, with performance concluding by June 24, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $37,266.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $27,768.48 to AmerisourceBergen Drug Corp on July 9, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $77,463.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective through August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award is non-set-aside and was competitively...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $130,093.44 to AmerisourceBergen Drug Corp on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The work will be...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D825F2B50Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,831.66 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's established role as a critical supplier of pharmaceutical products and medical supplies to federal defense health agencies, including the Defense Health Agency and U.S. Coast Guard. As a non-set-aside award, this contract was competitively procured and reflects the company's capability to meet federal standards for medication and medical commodity distribution. The pharmaceutical supplier's federal contract portfolio encompasses a comprehensive range of therapeutic products including specialty medications, generic and brand-name drugs, vaccines, and medical devices, enabling broad support for military healthcare programs globally through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 6/2/25 |